Internal Server Error

List of Otsuka's Acquisitions

lockFilter this list
Otsuka has made a total of 9 acquisitions. These were completed across 3 countries: United States, France, and Canada. The firm has invested across 9 sectors, including Neurology, Food Tech, and Life Sciences Tech. Peak activity occurred in 2017 and 2018, with 2 acquisitions each, and 2014, with 1. For the 2020–2025 period, the average number of acquisitions per year is 0, and 0 have been completed in the current calendar year. The most recent acquisition was Visterra, a Cambridge-based developer of monoclonal antibodies for infectious diseases founded in 2007; the acquisition took place in July 2018.

Here's the year on year acquisition history of Otsuka:

Year on year acquisition history of Otsuka20182017Acquisitions Round Date (Yearly)0123
  • Number of Total Acquisitions
Year
# Acquisitions
2018
2
2017
2
2014
1
2013
1
2008
1
1998
1
1989
1

Recent acquisitions by Otsuka

Otsuka's most recent acquisition - Visterra is a Developer of monoclonal antibodies against infectious diseases, founded in 2007 and located in Cambridge. Otsuka acquired it in July 2018 for a price of $*****.

Here is the list of all acquisitions by Otsuka sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Jul 11, 2018
szu{
wuwd
96
923
Jul 10, 2018
rmol
zl{l
94
951
Jul 27, 2017
bkfp
qlgn
83
443
Mar 02, 2017
floa
avgj
21
260
Dec 02, 2014
tgqi
nkdf
21
878

View the full list of acquisitions

Sign Up for Free

News related to Otsuka's acquisitions

lockFilter this list

Media has covered Otsuka for a total of 24 events in the last 1 year, 3 of them have been about acquisition activity.

View More Otsuka Recent News

FAQs about Acquisitions by Otsuka

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford